Evaluation of Prospective<i>HLA-B*13:01</i>Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy
Dapsone hypersensitivity syndrome (DHS) is the most serious adverse reaction associated with dapsone administration and one of the major causes of death in patients with leprosy, whose standard treatment includes multidrug therapy (MDT) with dapsone, rifampicin, and clofazimine. Although the HLA-B*1...
Wedi'i Gadw mewn:
Prif Awduron: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Fformat: | Artigo |
Iaith: | Saesneg |
Cyhoeddwyd: |
2019
|
Mynediad Ar-lein: | https://doi.org/10.1001/jamadermatol.2018.5360 https://jamanetwork.com/journals/jamadermatology/articlepdf/2729073/jamadermatology_liu_2019_oi_180083.pdf |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|